tradingkey.logo
tradingkey.logo
Search

Biomx Inc

PHGE
Add to Watchlist
0.186USD
-0.003-1.48%
Close 07-31 16:00ETQuotes delayed by 15 min
1.22MMarket Cap
LossP/E TTM

Shareholding Stats

Updated: Thu, May 14
Updated: Thu, May 14
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
T3 Defense Inc
12.86%
Segal (Gur Aryeh)
5.93%
Shohat (Elad)
3.46%
Shalom (Menachem)
2.97%
Cystic Fibrosis Foundation
1.30%
Other
73.48%
Shareholders
Shareholders
Proportion
T3 Defense Inc
12.86%
Segal (Gur Aryeh)
5.93%
Shohat (Elad)
3.46%
Shalom (Menachem)
2.97%
Cystic Fibrosis Foundation
1.30%
Other
73.48%
Shareholder Types
Shareholders
Proportion
Corporation
14.71%
Individual Investor
12.56%
Hedge Fund
2.16%
Holding Company
0.56%
Venture Capital
0.46%
Private Equity
0.38%
Research Firm
0.14%
Investment Advisor
0.02%
Other
69.01%

Institutional Shareholding

Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
36
319.22K
6.63%
-512.77K
2025Q4
41
528.98K
34.65%
-249.43K
2025Q3
38
10.55M
39.72%
-5.15M
2025Q2
48
19.36M
73.97%
+6.20M
2025Q1
47
17.95M
68.92%
+5.32M
2024Q4
47
13.90M
76.65%
+2.77M
2024Q3
43
13.00M
74.85%
+8.58M
2024Q2
33
4.45M
66.70%
+1.05M
2024Q1
34
2.97M
56.90%
+586.97K
2023Q4
35
2.25M
51.72%
+502.58K
View more

Shareholder Activity

Name
Shares Held
Proportion
Change
Chg %
Date
Cystic Fibrosis Foundation
131.27K
2.01%
+37.18K
+39.51%
Feb 27, 2025
Nantahala Capital Management, LLC
114.80K
1.75%
-16.43K
-12.52%
Dec 31, 2025
Deerfield Management Company, L.P.
65.64K
1%
-65.64K
-50.00%
Feb 09, 2026
Centaurus Investments Limited
56.32K
0.86%
+56.32K
--
Apr 21, 2025
AMR Action Fund LP
46.15K
0.71%
+30.07K
+187.05%
Sep 30, 2024
AIGH Capital Management, LLC.
38.17K
0.58%
+38.17K
--
Dec 31, 2025
View more
tradingkey.logo
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.